Uromems raised €44M in a Series C round in Jun 2024. The company is based in Grenoble, France. Investors in the round: B-to-V Partners, Bpifrance, Crédit Mutuel Innovation and 5 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
